Eledon Pharmaceuticals, Inc. (ELDN) Q2 2024 Earnings
ELDN·Reported August 19, 2024·Before market open
Diluted EPS came in at $-0.32, missed the $-0.31 consensus by $0.01.
Diluted EPS
$-0.32missed by $0.01
Consensus: $-0.31
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Eledon Pharmaceuticals, Inc.'s Q2 2024 earnings report.
Eledon Pharmaceuticals, Inc. (ELDN) reported Q2 2024 earnings on August 19, 2024 before market open.
Eledon Pharmaceuticals, Inc. reported diluted EPS of $-0.32 for Q2 2024.
EPS missed the consensus estimate of $-0.31 by $0.01.
You can read the 10-Q periodic report (0000950170-24-098590) directly on SEC EDGAR. The filing index links above go to sec.gov.